866-997-4948(US-Canada Toll Free)

Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential

Published By :

GBI Research

Published Date : Dec 2010

Category :

Therapeutic Area

No. of Pages : 126 Pages


GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential”, which provides insights into oncology sales and price forecasts until 2017. 

The report also examines the Indian oncology treatment usage patterns. In addition, the report also includes insights into the oncology R&D pipeline. The report provides an in-depth analysis of the top five oncology therapeutic indications, which are breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s Lymphoma (NHL). 

Scope

The report covers:

  • Data and analysis on the oncology market in India.
  • Annualized market data for the oncology market from 2002 to 2009, with forecasts to 2017.
  • Market data on the therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.
  • Key drivers and restraints that have had a significant impact on the market and on each indication.
  • The competitive landscape of the oncology market includes both Indian players and foreign players.
  • Key M&A activities and Licensing Agreements that took place from 2004 to 2010 in the Indian oncology market.

Reasons to buy

The report will assist business development and marketing executives to strategize their product launches, by allowing them to:

  • Build effective strategies to launch their pipeline products by identifying potential of the market.
  • Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
  • Develop key strategic initiatives by studying the key strategies of top competitors.
  • Develop market-entry and market expansion strategies by identifying each indication’s growth rate.
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.
Table of Contents

1 Table of Contents 3

1.1 List of Tables 6
1.2 List of Figures 8

2 Oncology Market in India: Introduction 10
2.1 GBI Research Report Guidance 11

3 Oncology Market in India: Market Characterization 12
3.1 Market Size 12
3.2 Annual Cost of Treatment 13
3.3 Treatment Usage Pattern 14
3.3.1 Diseased Population 15
3.3.2 Treated Population 16
3.4 Drivers 17
3.4.1 High Spending By Big Pharmaceutical Companies for Drug Trials 17
3.4.2 Larger Population Base 17
3.4.3 High Government Support and Initiatives 18
3.5 Barriers 19
3.5.1 Counterfeit Medical Products 19
3.5.2 Unfavorable Patent Law for Bigger Companies 19
3.5.3 Restrictive Pricing and Reimbursement Policies Causing Serious Problems in the Cancer Market Growth 19
3.5.4 Poor Infrastructure and Insufficient Trained Manpower 20
3.5.5 More than 80 Molecules to be launched Over the Next Seven Years, Leading to More Competition 20
3.6 Case Studies 21
3.6.1 Unfavorable Patent Law for Bigger Foreign Companies, Roche versus Cipla 21
3.6.2 Unfavorable Patent Law for Bigger Foreign Companies, Novartis Glivec 23

4 Oncology Market in India: Therapeutic Landscape 25
4.1 Introduction 25
4.2 Breast Cancer 25
4.2.1 Market Size 25
4.2.2 Average Annual Cost of Treatment 26
4.2.3 Treatment Usage Pattern 27
4.2.4 Drivers 29
4.2.5 Restraints 30
4.3 Colorectal Cancer 31
4.3.1 Market Size 31
4.3.2 Annual Cost of Treatment 32
4.3.3 Treatment Usage Pattern 33
4.3.4 Drivers 35
4.3.5 Restraints 36
4.4 Prostate Cancer 37
4.4.1 Market Size 37
4.4.2 Annual Cost of Treatment 38
4.4.3 Drivers 39
4.4.4 Restraints 39
4.4.5 Treatment Usage Pattern 39
4.5 Lung Cancer 42
4.5.1 Market Size 42
4.5.2 Annual Cost of Treatment 43
4.5.3 Drivers 44
4.5.4 Restraints 44
4.5.5 Treatment Usage Pattern 45
4.6 Non-Hodgkins Lymphoma 48
4.6.1 Market Size 48
4.6.2 Annual Cost of Treatment 49
4.6.3 Drivers 50
4.6.4 Restraints 50
4.6.5 Treatment Usage Pattern 51

5 Oncology in India: Regulatory Landscape 54
5.1 Major Regulatory Bodies in India 54
5.1.1 The Central Drugs Standard Control Organization (CDSCO) 54
5.1.2 State Drug Regulatory Authority (SDRA) 55
5.2 IPR Protection in India 56
5.2.1 Effect of Patent Laws on Pharmaceutical Production in India 58
5.2.2 Key Impact of Newer Patent Laws on India 58
5.3 Key Regulations for Conducting Oncology Research in India 59
5.4 Government Initiatives to Support Oncology Research in India 60
5.4.1 Focus Areas 61
5.5 Oncology in India: Pricing and Reimbursements 62
5.5.1 Pricing of Oncology Drugs in India 62
5.5.2 Reimbursement of Oncology Drugs in India 65

6 Oncology in India: Pipeline Analysis 67
6.1 Key Area Focus for R&D in India 67
6.2 Pipeline Segmentation by Clinical Phase of Development 67
6.3 Pipeline Segmentation by Indication 68
6.3.1 Lung Cancer 69
6.3.2 Breast Cancer 70
6.3.3 Colorectal Cancer 71
6.3.4 Non-Hodgkins Lymphoma 72
6.3.5 Prostate Cancer 73
6.4 Key Late Stage Pipeline Drugs 74
6.4.1 Lung Cancer 74
6.4.2 Breast Cancer 75
6.4.3 Colorectal Cancer 77
6.4.4 Non-Hodgkins Lymphoma 81
6.4.5 Prostate Cancer 84

7 Oncology in India: Competitive Landscape 88
7.1 Key Indian Players in the Indian Oncology Market 88
7.1.1 Dr. Reddys Lab 88
7.1.2 Piramal Healthcare 91
7.1.3 Biocon Limited 95
7.1.4 Cipla Ltd. 97
7.2 Key Foreign Players in the Indian Oncology Market 100
7.2.1 Sanofi-Aventis 100
7.2.2 F. Hoffmann-La Roche Ltd/Genentech, Inc. 104
7.2.3 AstraZeneca 107
7.2.4 GlaxoSmithKline 109

8 Deals Landscape 112
8.1 Mergers and Acquisitions 112
8.1.1 Deals by Year 112
8.1.2 Deals by Type 113
8.1.3 Deal by Value 114
8.1.4 Top 10 M&A Deals 115
8.2 Licensing Agreements 118
8.2.1 Deals by Year 118
8.2.2 Deals by Value 119
8.2.3 Key Takeaway 120
8.2.4 Top 10 Licensing Deals 120

9 Appendix 123
9.1 Market Definitions 123
9.2 Abbreviations 123
9.3 Research Methodology 124
9.3.1 Coverage 124
9.3.2 Secondary Research 124
9.3.3 Primary Research 125
9.3.4 Expert Panel Validation 125
9.4 Contact Us 125
9.5 Disclaimer 125
9.6 Sources 126

List of Table


Table 1: Oncology Market, India, $m, 20022009 12
Table 2: Oncology Market, India, $m, 2009-2017 12
Table 3: Oncology Market, India, Annual Cost of Treatment, $, 20022009 13
Table 4: Oncology Market, India, Annual Cost of Treatment, $, 20092017 13
Table 5: Oncology Market, India, Treatment Usage Patterns, 20022009 14
Table 6: Oncology Market, India, Treatment Usage Patterns, 20092017 14
Table 7: Oncology Market, India, Breast Cancer, Market Size, ($m), 20022009 25
Table 8: Oncology Market, India, Breast Cancer, Market Size, ($m), 2009-2017 25
Table 9: Oncology Market, India, Breast Cancer, Average Annual Cost of Treatment, 2002-2009 26
Table 10: Oncology Market, India, Breast Cancer, Average Annual Cost of Treatment, 2009-2017 26
Table 11: Oncology Market, India, Breast Cancer, Treatment Usage Patterns, 20022009 27
Table 12: Oncology Market, India, Breast Cancer, Treatment Usage Patterns, 2009-2017 27
Table 13: Oncology Market, Colorectal Cancer, India, Market Size, ($m), 20022009 31
Table 14: Oncology Market, Colorectal Cancer, India, Market Size, ($m), 20092017 31
Table 15: Oncology Market, Colorectal Cancer, India, Annual Cost of Treatment, ($), 20022009 32
Table 16: Oncology Market, Colorectal Cancer, India, Annual Cost of Treatment, ($), 20092017 32
Table 17: Oncology Market, India, Colorectal Cancer, Treatment Usage Pattern, 2002-2009 33
Table 18: Oncology Market, India, Colorectal Cancer, Treatment Usage Pattern, 2009-2017 33
Table 19: Oncology Market, India, Prostate Cancer, Market Size, ($m), 20022009 37
Table 20: Oncology Market, India, Prostate Cancer, Market Size, ($m), 20092017 37
Table 21: Oncology Market, India, Prostate Cancer, Annual Cost of Treatment, ($), 20022009 38
Table 22: Oncology Market, India, Prostate Cancer, Annual Cost of Treatment, ($), 20092017 38
Table 23: Oncology Market, India, Prostate Cancer, Treatment Usage Pattern, 20022009 40
Table 24: Oncology Market, India, Prostate Cancer, Treatment Usage Pattern, 20092017 40
Table 25: Oncology Market, India, Lung Cancer, Market Size, ($m), 20022009 42
Table 26: Oncology Market, India, Lung Cancer, Market Size, ($m), 20092017 42
Table 27: Oncology Market, India, Lung Cancer, Average Annual Cost of Treatment, ($), 20022009 43
Table 28: Oncology Market, India, Lung Cancer, Average Annual Cost of Treatment, ($), 20092017 43
Table 29: Oncology Market, India, Lung Cancer, Treatment Usage Pattern, 20022009 45
Table 30: Oncology Market, India, Lung Cancer, Treatment Usage Pattern, 20092017 45
Table 31: Oncology Market, India, Non-Hodgkins Lymphoma, Market Size, ($m), 2002-2009 48
Table 32: Oncology Market, India, Non-Hodgkins Lymphoma, Market Size, ($m), 2009-2017 48
Table 33: Oncology Market, India, Non-Hodgkins Lymphoma, Average Annual Cost of Treatment, 2002-2009 49
Table 34: Oncology Market, India, Non-Hodgkins Lymphoma, Average Annual Cost of Treatment, 2009-2017 49
Table 35: Oncology Market, India, Non-Hodgkins Lymphoma, Treatment Usage Pattern, 2002-2009 51
Table 36: Oncology Market, India, Non-Hodgkins Lymphoma, Treatment Usage Pattern, 2009-2017 51
Table 37: Oncology Market, India, Competitive Landscape, Dr. Reddys, Marketed Products, 2009 90
Table 38: Oncology Market, India, Competitive Landscape, Dr. Reddys, Product Pipeline, 2009 90
Table 39: Oncology Market, India, Competitive Landscape, Dr. Reddys, M&A , Licensing Deals, 2009-2010 91
Table 40: Oncology Market, India, Competitive Landscape, Piramal Life Sciences, Product Pipeline, 2009 93
Table 41: Oncology Market, India, Competitive Landscape, Piramal Life Sciences, M&A Deals, 2009-2010 94
Table 42: Oncology Market, India, Competitive Landscape, Biocon Limited, Marketed Products, 2009 96
Table 43: Oncology Market, India, Competitive Landscape, Biocon Limited, Product Pipeline, 2009 96
Table 44: Oncology Market, India, Competitive Landscape, Cipla Ltd., M&A Deals, 2009-2010 99
Table 45: Oncology Market, India, Competitive Landscape, Key Foreign Players, Sanofi-Aventis, Major Marketed Products, 2009 102
Table 46: Oncology Market, India, Competitive Landscape, Key Foreign Players, Sanofi-Aventis, Major Pipeline Products, 2009 103
Table 47: Oncology Market, India, Competitive Landscape, Key Foreign Players, F. Hoffmann-La Roche Ltd., Major Marketed Products, 2009 106
Table 48: Oncology Market, India, Competitive Landscape, Key Foreign Players, F. Hoffmann-La Roche Ltd., Major Pipeline Products, 2009 106
Table 49: Oncology Market, India, Competitive Landscape, Key Foreign Players, AstraZeneca, Marketed Products, 2009 108
Table 50: Oncology Market, India, Competitive Landscape, Key Foreign Players, AstraZeneca, Oncology Pipeline, 2009 109
Table 51: Oncology Market, India, Competitive Landscape, Key Foreign Players, GlaxoSmithKline Pharmaceuticals Ltd, Marketed Products, 2009 111
Table 52: Oncology Market, India, Competitive Landscape, Key Foreign Players, GlaxoSmithKline Pharmaceuticals Ltd, Pipeline Products, 2009 111
Table 53: Oncology Market, India, Deals Landscape, M&A Deals, 2004-2010 115

List of Chart


Figure 1: Oncology Market, India, $m, 2002-2017 12
Figure 2: Oncology Market, India, Annual Cost of Treatment, $, 2002-2017 13
Figure 3: Oncology Market, India, Treatment Usage Patterns, 2002-2017 14
Figure 4: Oncology Market, India, Total Diseased Population, 2002-2017 15
Figure 5: Oncology Market, India, Total Treated Population, 2002-2017 16
Figure 6: Oncology Market, India, Drivers and Restraints, 2009 18
Figure 7: Oncology Market, India, Case Studies, Roche versus Cipla, 2006-2010 21
Figure 8: Oncology Market, India, Case Studies, Novartis, 1993-2010 23
Figure 9: Oncology Market, India, Breast Cancer, Market Size, ($m), 2002-2017 25
Figure 10: Oncology Market, India, Breast Cancer, Average Annual Cost of Treatment, ($), 2002-2017 26
Figure 11: Oncology Market, India, Breast Cancer, Treatment Usage Pattern, 2002-2017 27
Figure 12: Oncology Market, India, Breast Cancer, Diseased Population, 2002-2017 28
Figure 13: Oncology Market, India, Breast Cancer, Treated Population, 2002-2017 29
Figure 14: Oncology Market, Colorectal Cancer, India, Market Size, ($m), 2002-2017 31
Figure 15: Oncology Market, Colorectal Cancer, India, Average Annual Cost of Treatment, ($), 2002-2017 32
Figure 16: Oncology Market, India, Colorectal Cancer, Treatment Usage Pattern, 2002-2017 33
Figure 17: Oncology Market, India, Colorectal Cancer, Diseased Population, 2002-2017 34
Figure 18: Oncology Market, India, Colorectal Cancer, Treated Population, 2002-2017 35
Figure 19: Oncology Market, India, Prostate Cancer, Market Size, ($m), 2002-2017 37
Figure 20: Oncology Market, India, Prostate Cancer, Average Annual Cost of Treatment, ($), 2002-2017 38
Figure 21: Oncology Market, India, Prostate Cancer, Treatment Usage Pattern, 2002-2017 39
Figure 22: Oncology Market, India, Prostate Cancer, Diseased Population, 2002-2017 40
Figure 23: Oncology Market, India, Prostate Cancer, Treated Population, 2002-2017 41
Figure 24: Oncology Market, India, Lung Cancer, Market Size, ($m), 2002-2017 42
Figure 25: Oncology Market, India, Lung Cancer, Average Annual Cost of Treatment, ($), 2002-2017 43
Figure 26: Oncology Market, India, Lung Cancer, Treatment Usage Pattern, 2002-2017 45
Figure 27: Oncology Market, India, Lung Cancer, Diseased Population, 2002-2017 46
Figure 28: Oncology Market, India, Lung Cancer, Treated Population, 2002-2017 47
Figure 29: Oncology Market, India, Non-Hodgkins Lymphoma, Market Size, ($m), 2002-2017 48
Figure 30: Oncology Market, India, Non-Hodgkins Lymphoma, Average Annual Cost of Treatment, ($), 2002-2017 49
Figure 31: Oncology Market, India, Non-Hodgkins Lymphoma, Treatment Usage Pattern, 2002-2017 51
Figure 32: Oncology Market, India, Non-Hodgkins Lymphoma, Diseased Population, 2002-2017 52
Figure 33: Oncology Market, India, Non-Hodgkins Lymphoma, Treated Population, 2002-2017 53
Figure 34: Oncology Market, India, Regulatory Landscape, Functions of CDSCO India, 2009 54
Figure 35: Oncology Market, India, Regulatory Landscape, Functions of SDRA India, 2009 55
Figure 36: Oncology Market, India, Regulatory Landscape, IPR Protection in India, 1963-2009 56
Figure 37: Oncology Market, India, Regulatory Landscape, Drug Approval Process Flow, 2009 59
Figure 38: Oncology Market, India, Regulatory Landscape, Number of Approved Clinical Trials by CDSCO, 2007-2010 60
Figure 39: Oncology Market, India, Regulatory Landscape, Current Pricing Practice in India, 2009 63
Figure 40: Oncology Market, Global Pipeline by Phase of Development, %, 2010 67
Figure 41: Oncology Market, Global Pipeline by Indication, %, 2010 68
Figure 42: Oncology Market, Lung Cancer, Global Pipeline by Phase of Development, %, 2010 69
Figure 43: Oncology Market, Breast Cancer, Global Pipeline by Phase of Development, %, 2010 70
Figure 44: Oncology Market, Colorectal Cancer, Global Pipeline by Phase of Development, %, 2010 71
Figure 45: Oncology Market, Non-Hodgkins Lymphoma, Global Pipeline by Phase of Development, %, 2010 72
Figure 46: Oncology Market, Prostate Cancer, Global Pipeline by Phase of Development, %, 2010 73
Figure 47: Oncology Market, India, Competitive Landscape, Dr. Reddys, SWOT Profile, 2009 89
Figure 48: Oncology Market, India, Competitive Landscape, Piramal Life Sciences, SWOT Profile, 2009 92
Figure 49: Oncology Market, India, Competitive Landscape, Biocon Limited, SWOT Profile, 2009 95
Figure 50: Oncology Market, India, Competitive Landscape, Cipla Ltd., SWOT Profile, 2009 98
Figure 51: Oncology Market, India, Competitive Landscape, Key Foreign Players, Sanofi-Aventis, SWOT Profile, 2009 100
Figure 52: Oncology Market, India, Competitive Landscape, Key Foreign Players, F. Hoffmann-La Roche Ltd., SWOT Profile, 2009 105
Figure 53: Oncology Market, India, Competitive Landscape, Key Foreign Players, AstraZeneca, SWOT Profile, 2009 108
Figure 54: Oncology Market, India, Competitive Landscape, Key Foreign Players, GlaxoSmithKline Pharmaceuticals Ltd, SWOT Profile, 2009 110
Figure 55: Oncology Market, India, Deals Landscape, M&A Deals, Deals By Year, 2009 112
Figure 56: Oncology Market, India, Deals Landscape, M&A Deals, Deals by Type, 2004-2010 113
Figure 57: Oncology Market, India, Deals Landscape, M&A Deals, Deals By Value, 2004-2010 114
Figure 58: Oncology Market, India, Deals Landscape, Licensing Deals, Deals By Year, 2006-2010 118
Figure 59: Oncology Market, India, Deals Landscape, Licensing Deals, Deals By Value, 2004-2010 119

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *